Sophie Hordijk on A New Cause of the Hereditary Bleeding Disorder of VWD Type 1
Zeldzame bloedstollingsstoornissen shared on LinkedIn:
”New insights into Von Willebrand disease thanks to research
The latest issue of the Dutch Journal of Hematology features an interview with Sophie Hordijk, PhD candidate at the Department of Hematology at Erasmus MC in Ruben Bierings’ research group.
Sophie recently published a study in the leading journal Blood, in which she and her colleagues identified a new cause of the hereditary bleeding disorder Von Willebrand disease type 1.
The study points to impaired secretion of Von Willebrand Factor by endothelial cells as a possible key to a better understanding of the condition.
Curious about the scientific article?
Read it here.
Want to know more about Sophie Hordijk, Ruben Bierings, and the NTvH journal?
Take a look on LinkedIn:
- Sophie Hordijk
- Ruben Bierings
- Nederlands Tijdschrift voor Hematologie (Dutch Journal of Hematology)
Read the full interview here.”
Read the full article in Blood.
Article: A novel cause of type 1 von Willebrand disease: impaired exocytosis of Weibel-Palade bodies due to biallelic MADD variants
Authors: Sophie Hordijk, Stijn A. Groten, Petra E. Bürgisser, Sebastiaan N. J. Laan, Georg Christoph Korenke, Tomáš Honzík, Diane Beysen, Frank W. G. Leebeek, Paul A. Skehel, Maartje van den Biggelaar, Tom Carter, Ruben Bierings

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 16:17Shailendra Singh: Bombay Hospital Jaipur Inaugurates New Facility with Voluntary Blood Donation Camp
-
Nov 13, 2026, 16:10Minka Zivkovic: UMC Utrecht Announces Research Analyst Vacancy in Thrombosis and Haemostasis
-
Nov 13, 2026, 16:02Rounak Dubey: Elsevier’s Upcoming Handbook Explores Digitalization in Transfusion Medicine
-
Nov 13, 2026, 15:50Maha Othman: CanVECTOR 2026 Highlights Research on Immunothrombosis and Cancer-Associated Thrombosis
-
Nov 13, 2026, 15:48Cedric Hermans: Advances in Gene Therapy for Haemophilia A
-
Nov 13, 2026, 15:45Strengthens Global Collaboration in Thrombosis and Hemostasis for 2027 – ISTH
-
Nov 13, 2026, 15:42David McIntosh: The Global Blood Shortage Crisis and the Urgent Need for National Action
-
Nov 13, 2026, 15:41JTH Highlights Future Directions in Thromboprophylaxis for Hospitalized Children
-
Nov 13, 2026, 15:21Wolfgang Miesbach։ Gene Therapy for Haemophilia B Is Cheaper Than Lifelong Factor IX Prophylaxis in Sweden